Dube Michael P — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Dube Michael P has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $168K.

Profile

Michael P. Dube is a corporate executive known for his role in the biotechnology sector, particularly with Intellia Therapeutics, Inc., a company focused on gene editing and CRISPR technology. He has been involved in various capacities within the company, contributing to its strategic direction and operational management.

Board memberships

• Intellia Therapeutics, Inc.

Awards & honors

• Contributed to advancements in gene editing technology
• Leadership role in a publicly traded biotech company

Recent Transactions

Companies — Last 90 Days

• Intellia Therapeutics, Inc. (NTLA) — 1 filings, last 2026-07-06

Frequently Asked Questions

Who is Dube Michael P?

Michael P. Dube is a corporate executive known for his role in the biotechnology sector, particularly with Intellia Therapeutics, Inc., a company focused on gene editing and CRISPR technology. He has been involved in various capacities within the company, contributing to its strategic direction and operational management.…

How many SEC Form 4 filings has Dube Michael P submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Dube Michael P been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 5 open-market sales ($168K) across all tracked filings.

Where can I see all of Dube Michael P's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week